Bern Center for Precision Medicine (BCPM)

The Bern Center for Precision Medicine (BCPM) and its members create a robust precision medicine approach to treating patients in health and disease:

The center was officially founded on May 20, 2019.
Seven pilot projects were selected for funding from the 1st pilot project call, eight pilot projects from the 2nd project call and six winning projects from the Covid-19/SARS-CoV-2 project call.
5 winning projects for Young Investigators were announced in November 2021.
6 winning projects in Cancer Research were selected and announced in June 2022.
1 winning project in Ethics and Data Exchange was selected in October 2022.
1 winning Lighthouse project was selected in July 2023.
Currently, more than 100 members have joined the center, among them important precision medicine platforms such as genomics, biobank, etc.

X
Youtube

News and Events

Awards

ISREC Tandem award

Immunotherapy in malignant pleural mesothelioma:
Primary pleural cancers such as the malignant pleural mesothelioma, a lung cancer related to asbestos exposure, are cancers that develop in the chest cavity. Mesothelioma is a devastating cancer of high unmet medical need, and its heterogeneous response to immune checkpoint blockade is the rate-limiting factor for improved treatment.

The project led by Drs. Peng, Ochsenbein and Schmid aims to discover novel immune targets and mechanisms of resistance to immunotherapy in mesothelioma patients

Oncology

Publications

Biomarkers indicate regression of liver cirrhosis

Researchers from the DBMR/BCPM (University of Bern and University Hospital of Bern) and the University of Vienna identified and validated a group of lipid biomarkers associated with regression of fibrosis that could used as non-invasive biomarkers for detecting regression of chronic liver disease.

Hepatology

Awards

SNSF Sinergia award for Axel Rominger, Kuangyu Shi and Quanzheng Li

Oncology

News Archive